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Abstract
The focus of this descriptive comparative study was to examine the relationship between
gender and depression and immune system function in patients with colorectal cancer.
The research questions were answered through secondary analysis, using data obtained
from the answers of 117 men and women (71 men and 46 women) enrolled in a
colorectal cancer study conducted between 1990 and 1991 in Pennsylvania. Descriptive
statistics were used to characterize the sample, and general estimating equations were
used to analyze depression and immune system function between men and women.
Depression was measured by the Beck Depression Inventory, and immune system
function was measured by natural killer cell levels. Results indicated that women
reported higher levels of depression at all points in time, but the results were not
statistically significant (B=2.065,/?=.151). Age was statistically significant (B=4.180,
p=.04l). Women did not demonstrate statistically significantly lower NK cell levels than
men (B=..271,p=.603) using GEE, although at all points in time, men's NK cell levels
were higher than women's. Age was not a significant factor in the NK cell level
differences (B=3.667,/>=.056). The study was confounded by the relatively small sample
size, and the high drop-out rate.

CHAPTER 1
INTRODUCTION
Cancer is the second most frequent cause of death in the United States, and
colorectal cancer is the third most frequently diagnosed malignancy in both men and
women (ACS, 2005). Although colorectal cancer rates have been steadily declining for
the past 50 years, its five year survival is only 65% for white patients of both genders,
and 55% for African-American men and women. According to the American Cancer
Society, cancer will strike 679,510 women each year and of these women, 11% will be
diagnosed with colorectal cancer, only slightly less than the number diagnosed with
breast cancer (Society 2005)).
Statement of the Problem
Women have traditionally been underrepresented in medical studies, even though
men and women have approximately the same lifetime risk (5.9% and 5.5% respectively)
of being diagnosed with the disease. Colon cancer incidence rises with age; 91% of new
cases are found in patients over the age of 50 (ACS, 2005). Compared to patients aged
less than 40, there is a 50-fold increase in colon cancer in patients aged 60-79 (ACS,
2005). Colorectal cancer prognosis is directly related to the extent the tumor has entered
1
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the bowel wall, the presence of lymph node involvement, and the presence of metastasis
(National Cancer Institute, 2007).
Early diagnosis through screening beginning at age 50 is key to survival. Annual
fecal occult blood testing (FOBT), primarily using rehydrated samples decreased
mortality from colorectal cancer by 33% in study of 48,000 patients (Mandel, Bond et al.,
1993). Screening sigmoidoscopy, using either a flexible or rigid sigmoidoscope, reduced
the mortality risk by 70% -90% in two studies of screened patients compared to patients
who were not screened (Selby, Friedman et al., 1992); (Newcomb, Norfleet et al., 1992).
The American Cancer Society recommends that adults begin yearly FOBT screening at
age 50, with sigmoidoscopy every five years (ACS 2005). Recurrent disease is found in
up to 33% of patients (Safi, Link et al., 1993), leading to repeated treatment.
Patients with depression are less likely to continue in rigorous treatment and
screening regimens. Depression has also been implicated in reduced functioning of the
immune system, including the tumor surveillance function of the immune system. Yet
little data exists about any differences between the immune systems of men and women,
and depression in men and women who are diagnosed with colorectal cancer. A link
between depression and immune system function can serve to identify those patients most
at risk for complications, and those at risk of failing to continue treatment in follow-up
care. Research is needed to examine the effects of colorectal cancer on men and women,
and the differences, if any, in depressive symptoms and objective markers of immune
function. The majority of completed studies did not include women, or did not analyze
the women as a group separate from the men. Women are more likely to suffer from
depression, and depression has been associated with reduced immune function. If women
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with colorectal cancer are more depressed than men, one would expect that their immune
function would suffer, leading to (potentially) more complications and poorer healing.
Purpose of the Study
Psychological state, particularly depression, has been implicated in reduced
functioning of the immune system. Researchers have demonstrated diminished natural
killer T-cell counts in patients reporting depression (Zorilla, Luborsky et al., 2001). In
addition, numerous researchers have documented differences in levels of reported
depression between men and women with cancer. Whether these differences are also
reflected in patients' reports of depression over time has yet to be determined. Similarly,
research has not established whether differences in depression translate into significant
differences in immune system function between genders. The purpose of this study was
to examine differences in levels of depression and immune function at three points in
time of the colorectal cancer treatment trajectory.
The study consisted of a secondary analysis of data obtained from a study
performed by Dr. Ruth McCorkle, from 1991 to 1992. The aim of the original study,
supported by NIH grant P50 NR 02324, was to examine the physiological and
psychological responses over time of patients with colorectal cancer. The McCorkle
research team investigated whether outcome expectations and emotional distress changed
over time, examined the interactions (if any) of outcome expectations and immune
status, and whether outcome expectations and coping changed, or were related
(Barsevick, Pasacreta et al., 1995; Orsi, McCorkle et al., 1996; Orsi, Tax et al., 1996).
Orsi, McCorkle, Tax, and Barsevick (1996) examined the relationship between
depression, depressive symptoms, and the immune system in patients with colorectal
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cancer. Sixty-three patients were studied six months post diagnosis. Fourteen percent of
patients reported depressive symptoms. Levels of NK cells were significantly lower in
patients with more severe depressive symptoms both preoperatively and postoperatively.
In addition, NK cell counts were lower than average in patients with more severe
depressive symptoms. Preoperative depressive symptoms predicted NK counts and
CD4/CD8 ratios (Orsi, McCorkle et al., 1996). Differences by gender were not
examined, although women comprised between 32% and 39% of the sample, rather men
and women were analyzed as one group. Findings indicated twice as many men as
women in the sample reported no or minimal symptoms depressive symptoms at the first
pre-operative visit, although women in general suffer from depression at roughly twice
the rate of men. However, there was no separate analysis of the effect of gender on the
interaction of depression and natural killer cell levels. This clearly requires further
investigation.
Specific Aims
The specific aims of this study were to:
1) Determine if there were differences between reported depression levels in men and
women diagnosed with colorectal cancer at four points in time (day of surgery, one week
post surgery, three months post surgery, and six months post surgery).
2) Describe the differences, if any, in NK cell levels in men and women diagnosed with
colorectal cancer at three points in time (day of surgery, three months post surgery, and
six months post surgery).
Conceptual Framework

The conceptual framework of the study was based on the work of McCorkle
integrating expectations about outcome of cancer treatment, depression, and immune
response in person recovering from surgery for colorectal cancer (Figure 1.) (Orsi,
McCorkle et al., 1996).

The model posits that emotional distress, defined here as

depression, leads to impaired immune responses (measured by NK cell level).

Figure 1.
Research Questions
1. Are women more likely to report more depressive symptoms than men in
adult patients diagnosed with colorectal cancer at four points in time (pre-surgical, 1
week post-surgery, one month post-surgery, and three months post surgery)?
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2. Do women demonstrate lower NK cell levels in adult patients diagnosed with
colorectal cancer at three points in time (pre-surgical, one week post-surgery, and three
months post surgery)?
Hypotheses
Based on gender differences in depression and reactions to the cancer diagnosis,
and the already discovered interaction between NK cells and depression, the following
hypotheses will be tested:
HI: Women will report a greater incidence of moderate to severe depressive symptoms.
H2: Women will demonstrate a more prolonged duration of depressive symptoms than
men.
Significance to Nursing
The Healthy People 2010 Initiative (Office of Disease Prevention and Health
Promotion, 2000) aimed to reduce deaths from colorectal cancer from 19.8 deaths per
100,000 persons between 2000 and 2003, to 13.9 deaths per 100,000 persons in the
United States. Detecting and removing precancerous colorectal polyps and detecting and
treating the disease in its earliest stages will reduce deaths from colorectal cancer (Office
of Disease Prevention and Health Promotion, 2000). Detected at its earliest stages,
colorectal cancer has a five year survival rate of 90%. However, only 38% of cases are
diagnosed while the tumor is confined to the wall of the bowel (Ries, Eisner et al., 2002).
Early detection is key to patient survival.
Healthy People 2010 lists depression as the most common disorder of mental
illness (Office of Disease Prevention and Health Promotion, 2000), p. 36. Objective 189b aims to increase the proportion of adults with recognized depression who receive
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treatment (p 36). Depression strikes twice as many women as men (Office of Disease
Prevention and Health Promotion, 2000) p 37, and depression rates are higher in adults
with coincident medical conditions. Some research has been conducted on the impact of
a cancer diagnosis on state of mind. Stommel, Kurtz, Given, and Given (2004) studied
860 older patients for one year after a cancer diagnosis; they found that depression was
predicted by cancer site and stage, co-morbidities, sociodemographic characteristics, and
indicators of physical functioning(Stommel, Kurtz et al., 2004). Arndt, Merx, Stegmaier,
Ziegler, and Brenner (2004) assessed quality of life in 439 patients in Germany one year
after diagnosis with colorectal cancer(Arndt, Merx et al. 2004). Patients with colorectal
cancer scored their physical, role, and cognitive, and global health functioning only
slightly worse than the general population. However, patients described more severe
limitations on the emotional and social functioning scales, as well as for physical
symptoms and financial difficulties. Ramfelt, Severinsson, and Lutzen (2002) used a
qualitative method to examine the emotional and interactional perspectives of the
meaning of illness in 52 patients with colorectal cancer over the course of 12 months
following diagnosis(Ramfelt, Severinsson et al., 2002). Using constant comparative
analysis, the researchers described a process in which patients tried to find meaning in
illness to achieve emotional coherence.
Klemm, Miller, and Fernsler (2000) examined the demands the illness of
colorectal cancer placed on 121 patients over time. Ninety-three percent of participants
thought about the value of life and how long they might live. Participants reported that
colorectal cancer placed the greatest demands on them in the realm of personal meaning,
and noted significant psychological and existential concerns (Klemm, Miller et al., 2000).
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Galloway and Gray don (1996) examined the relationship between uncertainty,
symptom distress, and discharge information needs in 40 patients after colon resection for
cancer. Patients identified information about treatment, complications, and activities of
daily living as highly important. Increased uncertainty was significantly associated with
increased discharge information needs (Galloway & Graydon, 1996).
Course of Treatment
Treatment of colorectal cancer depends upon the stage of the disease at the time
of diagnosis. Colorectal cancer is staged according the TNM classification system by
recommendation of the American Joint Committee on Cancer (Cancer 2003). The TNM
system classifies tumors according to the tumor's invasion of the surrounding tissue,
involvement of regional lymph nodes, and evidence of distant metastasis. As the tumor
grows, it progressively invades the layers of the colon from the interior to the exterior;
survival depends upon the degree of invasion of the colon and surrounding lymph nodes,
and metastasis to distant structures. Treatment in all stages begins with local excision of
the tumor, either polypectomy or laparoscopic or open surgical resection, with regional
lymph node dissection. Because colorectal cancer spreads aggressively through the
lymphatic system, it is recommended that at least 12 lymph nodes be examined to
confirm the absence of nodal involvement by tumor (National Cancer Institute, 2003). In
some cases, aggressive tumors which are too large to be excised are treated with
debulking and adjuvant therapy such as chemotherapy and radiation therapy. Creation of
a temporary or permanent colostomy is dependent on the size of the lesion and its
location. In addition, patients may be referred for consideration for inclusion in clinical
trials of biological or chemotherapy regimens.

9
Patients with extensive disease and metastases may face protracted courses of
adjuvant therapy. How patients cope with the diagnosis and treatment of all types of
cancer has been studied in both men and women, both qualitatively and quantitatively.
Colorectal cancer places significant psychological, social, and physical demands on the
patient, and all three domains have been studied. However, the impact of gender has not
been studied.
Definition of Terms
Colorectal cancer: Cancer that develops in the colon (the longest part of the large
intestine) and/or the rectum. Colorectal cancer encompasses a broad spectrum of
neoplasms ranging from benign growths to invasive tumors. The predominant cancer is
derived from the epithelial tissue of the colon and rectum. Lesions are classified into
three groups: 1) non-neoplastic polyps; 2) neoplastic polyps; 3) cancers.
Natural killer cells: Natural killer (NK) cells are small subset of large, granular
lymphocytes, but are neither B cell nor T cell lymphocytes. Natural killer cells possess
spontaneous cytotoxic activity against a wide variety of cells such as tumor cells and cells
infected with viruses. This activity occurs independently of any interaction with major
histocompatibilty complexes. In addition, NK cells influence lymphokine production,
and regulate humoral and cytotoxic immune responses, as well as hematopoiesis. Natural
killer cells activated by interleukin-2 (IL-2) serve to suppress tumor metastasis (Orsi,
Taxetal., 1996).
CEA: Carcinoembryonic antigen. A substance that is sometimes found in an increased
amount in the blood of people who have certain cancers, other diseases, or who smoke. It
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is used as a tumor marker for colorectal cancer. Higher levels of CEA prior to treatment
for colorectal cancer correlate with poor survival (Filella, Molina et al., 1992).
Chemotherapy: Treatment with drugs that kill cancer cells.
Polyp: A growth that protrudes from a mucous membrane.
Polypectomy: Surgery to remove a polyp.
Biological therapy: Treatment to stimulate or restore the ability of the immune system to
fight cancer, infections, and other diseases. Also used to lessen certain side effects that
may be caused by some cancer treatments. Also called immunotherapy, biotherapy,
biological response modifier (BRM) therapy, and BRM therapy.
Radiation therapy: The use of high-energy radiation from x-rays, gamma rays, neutrons,
and other sources to kill cancer cells and shrink tumors. Radiation may come from a
machine outside the body (external-beam radiation therapy), or it may come from
radioactive material placed in the body near cancer cells (internal radiation therapy,
implant radiation, or brachytherapy). Systemic radiation therapy uses a radioactive
substance, such as a radiolabeled monoclonal antibody, that circulates throughout the
body.
Assumptions
The assumptions on which this study was based include:
1.

All information collected by the primary investigators is accurate, and

reflects information about the course of treatment for colorectal cancer.
2.

All patients were treated as similarly as possible according to their

diagnostic stage and colorectal cancer treatment protocols.
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3.

All patients had economic access to equivalent levels of care for colorectal

cancer treatment.

CHAPTER II
REVIEW OF THE LITERATURE
Colorectal Cancer Incidence and Course of Treatment
Although the incidence of colorectal cancer has declined since 1998, it continues
to be the third most frequently diagnosed malignancy in men and women (Society 2005).
Colorectal cancer is considered to be a disease of the elderly, with over 91% of new cases
and 94% of deaths occurring in patients older than 50. The incidence of colorectal cancer
is 50 times higher in patients aged 60-79 than in those under the age of 40 (ACS, 2005).
Because of its high frequency in the aging population, colorectal cancer and patients'
reactions to it have been studied extensively. In addition to physiological reactions to
surgery and adjuvant therapies, much attention has been directed at how patients think
and feel over the course of treatment.
Depression and Cancer
Psychological responses to both the cancer diagnosis and course of treatment have
been studied since the 1970s. Wiesman and Worden (1976), Oberst and Scott (1984),
Morris, Greer and White (1977), and Hughes (1982) examined the psychological
responses of patients after various cancer diagnoses at various stages of diagnosis and
treatment; emotional distress was common. Weisman and Worden (1976) used a sample
of 120 patients with five different cancers (breast, lung, colon, Hodgkin's disease, and
malignant melanoma) to examine the effect of expectations and emotional distress on
12
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coping and health. Over the course of 100 days, patients were given the Minnesota
Multiphasic Personality Inventory (MMPI), the Thematic Apperception Test (TAT), and
the Profile of Mood States (POMS) in addition to scales on coping, resolution,
predominant concerns, and vulnerability which were designed for the study. Patients
were interviewed by social workers in an initial semi-structured interview and at four to
six week intervals. Patients with high emotional distress attempted to cope by reducing
their negative moods, such suppression, submission, and stoicism. While some relief was
found through the use of these tactics, they did ultimately resolve the underlying
problems. Patients with lower emotional distress used more functional strategies such as
eliciting partnerships with others and problem-focused tactics to resolve problems. While
they found that emotional distress and a pessimistic outlook were related, Weisman and
Worden did not examine the interrelationships between coping and expectations, leading
to a linear picture of cancer coping. Men and women were not analyzed separately. The
majority of the women in the study had been diagnosed with breast cancer, although
more women than men in the study had colon cancer(Weisman and Worden, 1976).
Oberst and Scott (1988) examined 40 patient-spouse dyads in which the patient
had been diagnosed with colorectal or urinary cancer. Dyads were assessed at six points
in the post-surgical period: pre-discharge, 10 days, 30 days, 60 days, 90 days, and 180
days post discharge; the Brief Symptom Inventory, the State-Trait Anxiety Inventory, the
Vulnerability Scale, and an inventory of concerns and problems were used. Both ostomy
and non-ostomy patients were used. Both spouses and patients reported similar numbers

of problems and concerns. Spouses reported more problems with their own physical
states and with emotional difficulty and handling their own feelings. Spouses reported
more lifestyle disruptions than patients. Spouses consistently reported more anxiety than
patients did at 90 days, and prior to discharge. All dyads exhibited symptoms which had
not resolved in the 180 day study period. The study was limited by its small sample size,
and use of a relatively homogenous sample of middle to upper income families. No
effort was made to distinguish between male and female patients in the analysis, and
depression was not specifically addressed (Oberst & Scott, 1988).
Stommel, Kurtz, Given, and Given (2004) looked at depression in 860 older
patients for one year after a cancer diagnosis, using the using the center for
Epidemiological Studies Depression Scale (CES-D). In the 393 patients who completed
the full study, they found that depression was predicted by cancer site and stage, comorbidities, education, gender, and a history of emotional problems. Overall depressive
symptoms declined over the course of the investigation, especially depressive mood and
somatic indicators. As might be expected, women exhibited higher depression scores
than men, although education, history of emotional problems, and site of cancer in the
lung had the highest association with depression. The study was limited to patients who
could be accessed by telephone, lived in Michigan, and spoke English. Only patients
aged 65 or older were recruited. The use of the CES-D also raises some concerns. The
CES-D has been criticized for its questions about somatic symptoms; researchers have
speculated that such questions might lead to exaggerations and over-reporting of
depressive symptoms(Stommel, Kurtz et al., 2004).
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Arndt, Merx, Stegmaier, Ziegler, and Brenner (2004) assessed quality of life in
439 patients in Germany one year after diagnosis with colorectal cancer using the
European Organization for Research and Treatment of Cancer (EORTC) Quality of Life
questionnaire (QLQ-C30). This 30-item self-report cancer-specific survey measures
health-related quality of life, and consists of five functional scales (physical, emotional,
role, cognitive, and social function). In addition, the questionnaire also evaluates somatic
symptoms such as fatigue and nausea and vomiting, and financial difficulties. In the 309
patients who completed the full questionnaire, quality of life was most affected by fatigue
and insomnia. Patients with colorectal cancer scored their physical, role, and cognitive,
and global health functioning only slightly worse than the general population. No
patterns related to gender were seen. However, patients described more severe
limitations on the emotional and social functioning scales, as well as for physical
symptoms and financial difficulties. The study was limited in that it did not specifically
assess depression or depressive symptoms scores. Patients were studied at one point in
time rather than over time with repeated measures, and were compared to the general
population rather than to themselves. Those who responded to the request to participate
in the study were better educated than nonresponders, and tended to be married. There
was no data on those patients who died in the year between diagnosis and the request to
participate, and whose quality of life might presumably be different from patients who
survived for one year (Arndt, Merx et al., 2004).
Will (2002) used a constant comparative method to investigate the process by
which patients learn to live with colorectal cancer. Using grounded theory, Will found
that patients used a process of self-talk to work through the experience of colorectal
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cancer. Patients experienced an 8 stage trajectory of living with colorectal cancer.
Phases consisted of: (1) Knowing something is wrong; (2) seeking diagnosis; (3)
receiving the diagnosis; (4) planning treatment; (50 being treated; (6) waiting and
monitoring; (7) something is wrong again; (8) reflecting and moving on (Will, 2002).
Depression and Natural Killer Cells
Depression has long been known to have a significant effect on the immune
system. Urch et al, (1988) compared the natural killer (NK) cell activity of in
schizophrenics and patients with depression undergoing treatment with that of normal
volunteers, and found that the schizophrenics had lower NK cell activity.
Psychopharmacologic treatment led to increases in NK cell activity in the patients with
schizophrenia, but not in those with depression. Urch et al concluded that the pituitaryadrenal axis was responsible for the difference, and that the decrease in NK cell activity
might be responsible for failures in immunosurveillance (Urch, Muller et al., 1988).
Unfortunately, while the study contained equal numbers of men and women (30 each),
the influence of gender was not examined. Failures in immunosurveillance have been
implicated in an increase in cancers in patients with depression (Shekelle, Raynor et al.,
1981; Shavit, Lewis et al., 1984; Herberman & Ortaldo, 1981).
Irwin et al (1988) examined NK cell activity during significant life events as well
as during bereavement, and documented reduced NK cell activity in women anticipating
or undergoing bereavement. Irwin found that in 28 women who were either grieving, or
anticipating the death of a spouse, NK levels fell. However, the decrease in NK cell
levels was not mediated by changes in plasma Cortisol levels; the adrenal cortex did not
appear to influence the NK cell decline. The researchers did not, however, measure the
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level of bereavement of the subjects, nor did they test for actual depression (Irwin,
Daniels et al., 1988).
Irwin, Smith, and Gillin (1987) also examined NK cell levels and activity in a
small group of men hospitalized for treatment with diagnosed major depression. Using a
sample of 19 men matched with 19 nonhospitalized normal volunteers, Irwin et al found
that the depressed patients had significantly lower NK cell activity. Depression was
measured with the Hamilton Depression Rating Scale, which has been criticized for not
discriminating between symptoms related to anxiety, and those related to depression.
Regrettably, no women were included in the study, so any possible gender differences
could not be investigated (Irwin, Smith et al., 1987).
In further work, Irwin et al (1987) explored the relationship between the effects of
different life events on NK cells in women over a 3 month period. The Hamilton Rating
Scale for Depression and the Social Readjustment Scale were used to quantify the
women's states of mind. NK cell function was reduced in women with higher depression
scores, as well as with higher scores on the Social Readjustment Rating Scale (Holmes &
Rahe, 1967). Severity of depressive symptoms was accompanied by lower NK cell
activity. However, the authors did not examine any differences between the effects of
depression, and any effects of major life events (Irwin, Daniels et al., 1987).
Levy, Herberman, Lippman, and d'Angelo (1987) found an association between
breast cancer, depression and fatigue, and lack of support at the time of diagnosis, and
reduced NK cell activity at three months after diagnosis. Seventy-five women diagnosed
with stage I or stage II breast cancer in a study comparing modified radical mastectomy
to wide excision with radical radiotherapy were enrolled in a study to examine the
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influence of fatigue, global adjustment to cancer, and social support on NK cell levels.
Previous work had established that peripheral NK cell levels predicted the presence of
cancer cells in axillary lymph nodes (Levy et al, 1985). Patients were interviewed
between five and seven days after surgery (mastectomy plus axillary node dissection, or
lumpectomy and lymph node dissection). In addition to an interview, patients filled out
the Profile of Mood States (POMS) self-report form, and were rated by two observers for
overall adjustment to their illness using the Global Adjustment to Illness Score (GAIS).
Assays of NK cells were taken at the time of the interview, as well as during an
outpatient visit three months later. Patients with lymph nodes positive for cancer
demonstrated low NK cell activity at initial interview and at the three month check-up.
In these patients, neither chemotherapy nor chemotherapy with radiation led to further
decreases in NK cell activity. Fatigue and social support accounted for 30% of the NK
cell activity decreases at three months. Patients reporting depressive, fatigue-like
symptoms and who reported a lack of family support at the first interview tended to show
a decrease in NK cell activity at the three-month follow-up (Levy, Herberman et al.,
1987). Based on these results, it appears that depression and a perceived lack of social
support at the time of initial surgery predicted NK cell activity three months later. The
authors posited that a lack of NK cell activity would lead to reductions in cancer
surveillance, and possibly an increase in the spread of the disease. However, no data
were followed to substantiate that surmise. Patients in the study were young (mean age
52), and no socio-economic data were provided. In addition, no data were provided
about race, co-morbidities, or family constellation.
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Vines, Gupta, Whiteside, Dostal-Johnson, and Hummler-Davis (2003) measured
natural killer (NK) cell counts and self-reports of depression in 24 patients with chronic
pain. Pain perception was positively correlated with depression and NK cell percentage.
Immune system function as measured by NK cell levels was significantly higher in
patients without pain (Vines, Gupta et al., 2003).
Nunes et al (2002) measured immune function in 40 patients with depression, and
compared them to the immune function of 34 matched non-depressed volunteers.
Immune function as measured by acute phase proteins was significantly decreased in the
depressed patients. However, NK cell levels were not tested. One notable strength of the
study was the ratio of women to men in the depressed group (2.6:1), which mirrored the
greater proportion of women diagnosed with depression. However, the lack of NK cell
levels is not helpful (Nunes, Reiche et al., 2002).
The development or progression of colorectal cancer has been linked to immune
function since the 1980s. Decreases in immune function, either by design or nature, have
been found to be associated with either the development or metastasis of colorectal or
other cancers. Talmadge, Meyers, Prieur, & Stanley (1980) found an association between
NK cells and tumor growth in mice (Talmadge, Meyers et al., 1980). Letsou, Ballantyne,
Zdon, Cambria, & Modlen, (1985) reported increases in renal cell carcinoma in patients
after renal transplant associated with drug-induced immunosuppression (Letsou,
Ballantyne et al., 1986). Weese, Gilbertson, Syrjala, Whitney, & Starling, (1985) were
able to reduce the incidence of colon cancer metastasis in mice through
immunostimulation (Weese, Gilbertson et al., 1985).
Immune System Function
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The immune system discriminates between native and non-native cells within the
body, and protects the body from invading pathogens. The immune system also carries
out a significant internal surveillance function, designed to recognize cancer cells arising
from errors in cell division, and eliminate them. Overly aggressive immune cells
attacking the body's native cells have been implicated in the development of autoimmune
disorders such as multiple sclerosis, insulin-dependent diabetes, rheumatic arthritis, and
Crohn's disease, to name a few.
There are two arms in the immune system: the humoral-mediated immune
system, and the cellular-mediated system. Humoral immune responses include the Blymphocytes and their serological products, while the cellular-mediated system consists
of the T-lymphocytes,, the thymus, lymph nodes, blood vessels, and spleen. Both Blymphocytes and T-lymphocytes arise from the bone marrow. T-lymphocytes migrate to
the thymus gland in the neck, where they differentiate into several subtypes: cytotoxic Tlymphocytes, known as natural killer (NK) cells, T-helper lymphocytes, and T-suppressor
lymphocytes. The T-lymphocytes then travel to the blood vessels, lymph nodes, and
spleen to await activation by a pathogen. B-lymphocytes are responsible for the
antibody-mediated response to pathogens or abnormal internal cells. All B-lymphocytes
begin their life spans as secretors of immunoglobulin M (IgM).
When an invading organism or an abnormal cell is detected by the immune
system, the macrophage mounts the first response. The macrophage cell surface engages
the antigen with the major histocompatibility complex on the cell surface, leading to the
secretion of interleukin-1 (IL-1). Interluekin-1 resets the hypothalamus to a higher normal
set point, leading to the fever associated with infection; interleukin-1 also encourages the
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proliferation of T-lymphocytes and B-lymphocytes. Both natural killer T-lymphocytes
and helper T-lymphocytes respond to IL-1. Both natural killer and helper T-lymphocytes
secrete immunoglobulins that modulate their adherence to major histocompatibility
complexes formed by the interaction of macrophages and antigens. Natural killer Tlymphocytes possess specific binding sites on their cell surfaces that recognize and bind
antigens as the antigens are presented to them by the macrophage. The NK cell then
recognizes and responds to that specific antigen, leading to a faster T-lymphocyte
response when the antigen is encountered again. Natural killer lymphocytes are
evaluated with the CD-8 count, a measure of the expression of Cluster Determinant 8. Thelper lymphocytes are evaluated with the CD-4 count, a measure of the expression of
Cluster Determinant 4. T-helper lymphocytes secrete interleukin-2, a cytokine, in
response to antigens, and regulate the proliferation of T-lymphocytes in responses to
antigens. When stimulated by T-helper lymphocytes secreting factors such as
interleukin-2 and interleukin-4, B-lymphocytes change their antibody-secreting status and
begin secreting other classes of antibodies (IgE, IgG, IgD) specific to the antigen
presented to them by the T-helper cell. B-lymphocytes also proliferate at this stage, and
maintain an antigen-specific response.
Natural killer cell number and activity serves as quick method of evaluating
immune system function, and has received some attention in the era of acquired immune
system diseases. However, in patients with human immunodeficiency virus (HIV)
infection, the CD-4 count has been used as a marker of HIV infection in patients prior to
seroconversion, because few diseases other than HIV infection so closely effect the CD5 count.
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Conclusion
The review of the literature supports the research design of this study, and the
examination of the study variables in the conceptual framework. The review points to the
extraordinary lack of attention paid to the experiences of women in the study of
colorectal cancer, and the implications of colorectal for patients' psychological wellbeing. The majority of the studies did not include women, or did not analyze the women
as a group separate from the men. Women are more likely to suffer from depression, and
depression has been associated with reduced immune function. If women with colorectal
is

cancer are more depressed than men, one would expect that their immune function would
suffer, leading to (potentially) more complications and poorer healing.
In summary, the review of the literature indicates that further research is needed
to examine the relationship between gender, depression, and immune function in patients
with colorectal cancer. A secondary analysis of data which includes both men and
women can be conducted to illuminate any relationships. The knowledge gained from
this analysis could be used to formulate gender-specific treatment plans, and improve
outcomes for patients with colorectal cancer.

CHAPTER III
METHOD
The purpose of this study was to examine gender differences in the relationship
between depression, and immune function in patients with colorectal cancer over time. In
this chapter the research design, sample and sample, procedures for data collection,
measurement, as well as the data analysis techniques are described. The protection of
human subjects is also discussed.
Design
A descriptive, correlational, repeated measures design using secondary data
analysis was used for this study. Polit and Beck define secondary analysis as a form of
research in which the data collected by one researcher are reanalyzed by another
researcher to answer new research questions (Polit and Beck, 2004 p. 731). Although the
database must be selected with care, there are numerous advantages to conducting a
secondary analysis. Perhaps the greatest advantage lies in the money, time, and resources
which are conserved by using data which have already been collected (Moriarty, Deatrick
et al., 1999). In addition, the researcher does not need to impose upon the time and
patience of the members in the database, nor invade their privacy once again. If the
sample is large enough, the database may contain considerably more variables than could
be obtained in a smaller sample. A secondary analysis may allow the researcher to
reexamine data, and rethink previous conclusions. Finally, the researcher may be able to
23
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use a secondary analysis to as a preliminary study to solicit additional funds for further
research (Moriarty, Deatrick et al., 1999).
This study used a subsample of participants (n = 117) who participated in a larger
study conducted by McCorkle and colleagues to examine the physiological and
psychological responses over time of patients with colorectal cancer. The sample utilized
in this study was selected for several reasons. The database consisted of unequal
numbers of men and women. The unequal numbers may point to pre-existing differences
between the groups in their willingness to participate, or to continue to participate once
enrolled. The unequal numbers may reflect the overall demographic makeup of the
population, or the tendency of women to request medical care later in an illness trajectory
than men. Numerous other reasons may lie behind the unequal numbers, but the
preponderance of men could make drawing conclusions problematic.
The data were collected prospectively, included data collection points throughout
the illness trajectory, and standardized measures of depression and immune system
function, in addition to demographic data. Finally, the data were made available by the
researcher who collected them, who encouraged the secondary analysis.
McCorkle Study
A repeated measure prospective design was used to examine the physiological
and psychological responses over time of patients with colorectal cancer.
Sample and Sampling
Patients diagnosed with colorectal cancer were identified by the surgical
scheduling offices and then recruited from the four hospitals of the University of
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Pennsylvania for three months during their recovery from surgery from 1990 to 1992. To
achieve a power of .80 using three independent variables and 2 covariates, based on R =
.10 and alpha = .05, 121 were required for the study (Cohen 1988; Orsi, Tax et al. 1996).
All subjects were selected on the basis of the following criteria:
1. Dukes Stage A or B (TNM stages I and II) carcinoma of the colon or rectum.
2. Scheduled for surgery for colon or rectal cancer.
3. Able to communicate in English.
4. Oriented to time, place, and person.
Two hundred eligible patients were invited to join. Thirty-four percent refused,
either
due to fatigue or preoccupation, desire to avoid further blood draws, or family preference.
After informed consent was obtained, participants were asked to complete a demographic
survey, as well as an evaluation of the impact of their cancer on their state of mind, the
Beck Depression Inventory. The Beck Depression Inventory (BDI) a 21 item self-report
test measuring characteristic attitudes and symptoms of depression. Blood was drawn for
lymphocyte assay, which was determined by flow cytometry measurements. The initial
interview was conducted by a graduate student on the study team, and lasted between 30
and 45 minutes.
Data were collected prospectively at four points in time: 1) prior to surgery; 2) 1
week after surgery; 3) 1 month after surgery; 4) 3 months after surgery (Orsi, Tax et al.
1996). Each participant completed the Beck Depression Inventory each time. Blood
samples were obtained for NK Cell Assay at the initial (pre-operative) visit, as well as at
1 week and 3 months.

Table 1. Data Collection Time points
Time Point

Prior to Surgery

Measure

Beck
NK Cell Assay

1 Week
Post-Op
Beck
NK Cell Assay

1 Month
Post-op
Beck

3 Months
Post-op
Beck
NK Cell Assay

The demographic make-up of the patients who began the study is presented
below. Mean age of the participants was 62.4 years, with the mean age of the women
equal to 62.0 years, and the mean age of the men 62.3 years. The participants were
grouped according to their reports of depressive symptoms for the purposes of analysis
(Orsi, McCorkle et al.,1996). Chi-square analyses were conducted to determine if there
were any pre-existing differences between the demographics of the two groups. The
groups were similar with the exception that those with no or minimal depressive
symptoms were more likely to be married (X2 = 2.98, p - .05) (Orsi, McCorkle et al.,
1996). No differences were discerned with respect to age, employment, socioeconomic
status, education, race, and presence or absence of an ostomy (Orsi, McCorkle et al.
1996). Twenty-seven percent of the subjects were mild to moderately depressed
according to the criteria established by the Center for Cognitive Therapy (Beck, Ward et
al., 1961).
Table 2.
Gender Breakdown by Sampling Time
PreOp

1 week

30 Days

90 Days

Male n(%)

71(61%)

60(65%)

59(68%)

58(64%)

Female n(%)

46(39%)

32(35%)

28(32%)

32(36%)

Total n(%)

117(100%)

92(100%)

87(100%)

90(100%)

The mean BDI score for those patients reporting more severe symptoms was 16.0
(±7.5), indicating mild to moderate depressive symptoms (Orsi, McCorkle et al., 1996).
The mean BDI score for the patients with no or minimal depressive symptoms was 3.3
(±2.5).
The original investigators used t tests to look for differences in the preoperative
lymphocyte phenotype measure based on the demographic and clinical characteristics.
They reported no significant differences in the phenotype measures on any of the
demographic and clinical characteristics. However, they did find a clear and significant
difference in the relative lymphocyte levels between those patients reporting minimal or
no depressive symptoms, and those with depressive symptoms. Patients with depressive
symptoms prior to surgery had lower NK cell levels and CD8 levels, as well as lower T
helper (CD4) counts. Not surprisingly, their ratios of CD4 to CD8 were lower. Patients
with more depressive symptoms had significantly higher T helper counts (CD4), and
higher CD4/CD8 ratios, and significantly lower NK cell counts. Postoperatively, patients
with an ostomy had significantly lower CD4 counts, and patients receiving adjuvant
therapy had significantly lower CD4 counts, CD4/CD8 ratios, and significantly higher
CD8 counts. The mean BDI score post surgery for patients reporting more depressive
symptoms was 17.6 (±8.0), while the mean BDI score for patients with no or minimal
depressive symptoms was 2.9 (±2.7). This translates to a moderate level of depression.
At 3 months, patients in both groups had a slight increase in NK cell counts, and a
significant decrease in depression scores as measured by the BDI. Patient who reported
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depressive symptoms preoperatively continued to show significantly lower NK cell
counts at the 6 month evaluation.
The original team used stepwise multiple regressive analyses of the immune
system to assess the impact of various factors on NK cell counts. The level of depressive
symptoms reported, presence of an ostomy, occupation, and marital status predicted NK
cell counts. The presence of more severe preoperative depressive symptoms explained a
large amount of the variance in NK cell counts. Depression explained 7% of the variance
in NK cell counts. Use of adjuvant therapy accounted for 10% of the variance in
CD4/CD8 ratios at 6 months. The presence of an ostomy predicted 11% of the variance
in CD4 counts after surgery.
Overall, 27% of patients reported mild to moderate depression as measured by the
BDI (Orsi, McCorkle et al., 1996). The 24 women constitute a cohort whose
psychological state can be linked to their immune system function. Postoperative
depression was present at the 3 month evaluation, which demonstrates an extraordinary
duration of suffering. What is not known about this group of depressed patients is
whether the men and women had different trajectories of depression, and how this might
affect their eventual outcomes.
Rose Study
For the study presented here, 117 patient records were available for analysis. Of
these 117 cases, there were 71 men and 46 women at the initial sampling time, and the
ratio of men to women who remained in the sample was consistent at each sampling
point. Attrition was 25% for men between Time 1 and Time 2, 0 between Time 2 and
Time 3, and 2% between Time 3 and Time 5. For women, the attrition was 37% between
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Time 1 and Time 2, 3% between Time 2 and Time 3, and 0 between Time 3 and Time 4.
Table 3 presents the number and percentage of men and women who participated in the
study at each sampling point.
Table 3.
Gender Breakdown by Sampling Time
Pre-operative

1 week

30 Days

90 Days

Male n (%)

71 (61%)

60 (65%)

59 (68%)

58 (64%)

Female n (%)

46 (39%)

32 (35%)

28 (32%)

32 (36%)

Total

117(100%)

92(79%)

87 (74%)

90 (77%)

Unfortunately, demographic data on the patients were not made available for the
purposes of this analysis, thus necessitating the use of previously published data. (See
page 314, Orsi, McCorkle, et. al. (1996)
Measurement
Beck Depression Inventory
Depression defined as a score of 21 was measured by the use of The Beck
Depression Inventory (BDI) introduced by Beck, Ward, Mendelson, Mock, and Erbaugh
in 1961, and revised in 1971. The Beck Depression Inventory is a 21 item self-report test
measuring characteristic attitudes and symptoms of depression. It takes approximately 10
minutes to complete, and requires a fifth or sixth grade reading ability. A shorter, 13
item inventory is also available, but was not used in this study. Internal consistency
ranges from 0.73 to 0.92, with a mean internal consistency of 0.86 (Beck, Steer et al.,
1988). Cronbach's alpha is 0.93. Content validity was obtained by review by experts in
the symptoms of depressed patients. Concurrent validity with clinical ratings of
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depression ranges from 0.62 to 0.66; there are moderate correlations between the revised
Beck Depression Inventory and other depression scales, including the Hamilton
Psychiatric Rating Scale for Depression (0.73), the Zung Self-Reported Depression Scale
(0.76), and the Minnesota Multiphasic Personality Inventory Depression Scale (0.76)
(Groth-Marnat, 1990). Groth-Marnat also reported that the revised Beck Depression
Inventory was able to discriminate between psychiatric patients and non-psychiatric
patients, and yielded relatively higher scores for patients with major depressive disorders
as compared to patients with dysthymic disorders. Scores on the Beck Depression
inventory range from zero to 63 in patients diagnosed with depression. The test is scored
differently for the general population, and those who have diagnosed with depression. In
both groups, higher scores indicate greater depression. In the general population, a score
of 21 or greater indicates depression. In those patients diagnosed with depression, mild
to moderate depression levels begin at 10-18, moderate to severe depression scores range
from 19 to 29, and severe depression scores range from 30 to 63. Groth-Marnat (1990)
suggested that any score above 40 was indicative of possible exaggeration of depression,
and might be found in histrionic patients or those with borderline personality disorders.
Scores below 4 were deemed below usual scores in normal persons, and might represent
faking or denial of depression. For this analysis, subjects were assigned to one of two
groups: minimal or no depressive symptoms (scores less than 21), and more severe
depressive symptoms (scores 21 or greater) (Orsi, McCorkle et al., 1996). Continuous
variables were used for this analysis.
Flow Cytometry Evaluation

31
Flow cytometry was used to evaluate the numbers and types of immune cells. In
flow cytometry, cells are measured by exposing them to fluorescent monoclonal
antibodies that have been manufactured to react with the antigens present on each cell
surface. After reacting with the fluorescent monoclonal antibodies, the resulting cellantibody complexes produce different colors and degrees of fluorescence, and are
counted in flow cytometry chamber. Flow cytometry measurements have been used in
predicting responses to bone marrow and solid organ transplantation, the evaluation of
immune system dysfunction (Tax, Orsi et al., 1994). The results can be obtained in as
little as two hours, and are reliable and reproducible (Tax, Orsi et al., 1994). Monoclonal
antibodies against specific surface antigens on the lymphocytes were purchased from
Becton-Dickinson (Mountain View, California). These antibodies had been conjugated
with one of two fluorescing solutions: fluroescein isothiocyanate (FITC), which can be
detected by green emission in the flow cytometer, or phycoerythrin (PE), which can be
detected by red emission in the flow cytometer. Using two different fluorescing stains
allows the lymphocytes to be labeled with two different antibodies. Samples of
ethylenediaminetetraacetate (EDTA)-anticoagulated blood were incubated with the
monoclonal antibodies. A lysing solution was then added to remove the erythrocytes,
leaving the lymphocytes and platelets. The remaining cells were sedimented in a
centrifuge, washed, and fixed in a parformaldehyde solution. A Becton-Dickinson FACScan flow cytometer was used to perform the two-color flow cytometry analysis as
described by Siegal et al (1989). A sum check on the values obtained from the flow
cytometry analysis for each patient was performed (Tcells + Bcells +NK cells = 100%)
according to the Riechert method (Reichert, DeBruyere et al., 1991). Based on this

32

check, only 1 sample of the 95 obtained was eliminated from the analysis. The sum
check for the remaining samples ranged from 95% to 105%, with a mean of 100%.
Results from the flow cytometry analysis were expressed as percentages of lymphocyte
phenotypes rather than absolute numbers of cells.
Data Analysis
The original investigator made Beck Depression Inventory and Natural Killer cell
levels and gender available to this researcher. The data were entered by the researcher
into a database of the Statistical Package for the Social Sciences (SPSS) version 16.0,
Graduate Pack. Data entries were double-checked by the researcher and an associate, and
no data entry errors were found. The study was approved by the Institutional Review
Board for the protection of human subjects and the University of San Diego Institutional
Review Board.
Descriptive statistics were used in this analysis. Prior to statistical analysis,
missing data points were identified and analyzed by gender. The drop-out rate was
extraordinarily high, perhaps because of the longitudinal nature of the investigation.
Missing data for both depression scores and NK cell levels were imputed using the
General Estimating Equation analysis.
Descriptive Statistics
Descriptive statistics for the sample were drawn from the published work of the original
investigators and used to compare the samples according to depressive symptom
reporting (Munro 2001) (Orsi, McCorkle et al. 1996) (Tax, Orsi et al. 1994).
Power Analysis
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Power is influenced by the type of statistical test being performed, the size of the
sample, the size of the effect being measured, and the level of error specified in the
research. General estimating equation analysis was used to test for differences between
the mean scores for depression and NK cell levels at four points in time for depression,
and three points in time for NK cell levels, and between the two genders (Hanley,
Negassa et al., 2003). General estimating equations (GEE) are of particular value when
the data to be analyzed consist of longitudinal data, correlated data, in studies with
considerable missing data points, or if the data are binary or counts (Hanley, Negassa et
al., 2003). The GEE analysis is a regression analysis based on the General Linear Model
(GLM), and develops a regression equation for each set of data points to impute missing
data. The GEE method assumes that the model being tested is linear, and that any
missing data are missing completely at random (Horton & Lipsitz, 1999; Norton, Bieler
et al., 1996). General Estimating Equations are a synthesis of Feasible Generalized Least
Squares approach and are of particular value in data sets with missing data. General
Estimating Equations produce reasonably accurate standard errors, which produces
confidence intervals with the correct coverage rates (Hanley, Negassa et al., 2003).
The size of the sample required to demonstrate an effect can be the limiting factor
in an investigation. If the effect is small, the size of the sample may need to be extremely
large, and prohibitively expensive. If the effect is large, a smaller sample size may be
required. The power analysis used by the original investigators led them to recruit 200
participants. The size of the effect, in this case the sex of the participants, has been
shown to be significant in other studies of depression as noted earlier, but not in studies
of natural killer cells. The simplest approach to determine power in this analysis is to

34

estimate the effect size, or eta-squared (n ). Eta-squared represents the proportion of the
variance explained by the analysis (Polit & Beck, 2004) p.498). Finally, the level of error
was set a priori at/K0.05.
Table 4
Schedule of Tests for Men and Women Participants
Prior to Surgery

1 Week
Post-Op

1 Month
Post-Op

3 Months
Post-Op

Sex
BDI
Men

BDI

BDI

BDI
NK Cell Assay

NK Cell Assay

NK Cell Assay
BDI
Women

BDI

BDI

BDI
NK Cell Assay

NK Cell Assay

Limitations
There were several limitations to this study. While the overall number of
participants was moderately sized, not all the data could be retrieved. The data were also
drawn from the catchment area of a large metropolitan hospital in the northeastern corner
of the United States, and included primarily elderly participants. Seventy-four percent of
the participants were over the age of 56. Since 91% of new diagnoses of colorectal
cancer occur in patients over the age of 50, it is likely that this sample underestimates the
population mean for depressive scores and NK cell levels. The data were gathered in the
1990s. Since that time, colorectal cancer has received more publicity and more attention
from the public, particularly since the death of newscaster Katie Couric's husband in
1998. After Couric underwent a televised colonoscopy in 2000, a study published in the
Archives of Internal Medicine noted an increase in patients undergoing colonoscopy for
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cancer screening. In addition, only 9 participants (10%) were African-American.
African-Americans die from colorectal cancer at 40% higher rate than Caucasian men
and women, and are more likely to be diagnosed at a more advanced stage of the disease
(ACS, 2005).
Finally, the data are limited by the attrition rate. The treatment of the missing
data has already been discussed. By the time of the first post-operative visit, one week
after surgery, 15% of the men and 30% of the women had dropped out of the study or
simply did not complete their depression score instruments. At one month, an additional
2% of men and 9% of women were lost to follow-up, and at three months, a total of 18%
of men and 30% of women had dropped out of the investigation. At all data points,
women were lost to follow-up at approximately twice the rate of men.
Similar results were found when the NK cell counts were analyzed. Results were
available for 55 men and 34 women at the pre-operative visit. By the time of the postoperative interview at 1 week, 29% of men had opted out, and 38% of women. At three
months, 36% of men and 42% of women dropped out of the study or their results could
not be found. At all points, more women than men dropped out.
Human Subjects
To protect participants from risk or injury, the original investigators submitted the
study proposal to the Committee on Studies Involving Human Beings at the University of
Pennsylvania. For the secondary analysis, the proposal was submitted for approval by
this investigator to the Institutional Review Board of the University of San Diego.
Appendix B contains the approval letter from the University of San Diego. The original
investigators hold the approval letter from the University of Pennsylvania.
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The data collection tools were kept locked in a secure location by the original
investigators, and made available to this researcher. All participants were coded by
numbers rather than by names, and the original investigators kept the names separately
from the coded data tools to maintain anonymity.
There were no potential physical, psychological, or social risks to the subjects in
this secondary analysis. The findings will be used to assess the relationship, if any,
between gender and depression and natural killer cell levels in patients with colorectal
cancer.
Summary
The purpose of this study was to investigate the influence of gender on depression
and natural killer cell levels in patients with colorectal cancer over a 3 month period. The
data analysis is appropriate for the types of data collected, the purpose of the study, and
the method used. It is hoped that the results of the data analysis provided information
useful in the formulation of treatment plans for patients with colorectal cancer.

CHAPTER IV
RESULTS
The results of the analysis are presented in two sections. Section one describes
the sample's demographics. Section two presents the analysis of the influence of gender
on participants' reporting of depressive symptoms, and NK cell levels.
Description of the Sample
The demographic breakdown of the sample can be found in Table 5. The original
investigators used t tests to look for differences in the preoperative lymphocyte
phenotype measure based on the demographic and clinical characteristics. They reported
no significant differences in the phenotype measures on any of the demographic and
clinical characteristics. However, they did find a clear and significant difference in the
relative lymphocyte levels between those patients reporting minimal or no depressive
symptoms, and those with depressive symptoms. Patients with depressive symptoms
prior to surgery had lower NK cell levels and CD8 levels, as well as lower T helper
(CD4) counts. Not surprisingly, their ratios of CD4 to CD8 were lower. Patients with
more depressive symptoms had significantly higher T helper counts (CD4), and higher
CD4/CD8 ratios, and significantly lower NK cell counts. Postoperatively, patients with
an ostomy had significantly lower CD4 counts, and patients receiving adjuvant therapy
had significantly lower CD4 counts, CD4/CD8 ratios, and significantly higher CD8
counts. The mean BDI score post surgery for patients reporting more depressive
37
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symptoms was 17.6 (±8.0), while the mean BDI score for patients with no or minimal
depressive symptoms was 2.9 (±2.7). This translates to a moderate level of depression.
At 3 months, patients in both groups evinced a slight increase in NK cell counts, and a
significant decrease in depression scores as measured by the BDI. Patient who reported
depressive symptoms preoperatively continued to show significantly lower NK cell
counts at the 6 month evaluation.
The original team used stepwise multiple regressive analyses of the immune
system to assess the impact of various factors on NK cell counts. The level of depressive
symptoms reported, presence of an ostomy, occupation, and marital status predicted NK
cell counts. The presence of more severe preoperative depressive symptoms explained a
large amount of the variance in NK cell counts. Depression explained 7% of the variance
in NK cell counts. The presence of an ostomy predicted 11% of the variance in CD4
counts after surgery.
Table 5
Subjects' Preoperative Demographic and Clinical Characteristics
Characteristics

Minimal or No
Depressive Symptoms
N = 46

Depressive Symptoms

31 (67%)
15 (33%)

8 (47%)
9 (53%)

64
37-63

59
30-87

41 (89%)
5(11%)

16(94%)
1 (6%)

40 (89%)
6 (13%)

11 (65%)
6 (35%)

N=17

Sex
Male
Female
Age
Range
Mean
Race
Caucasian
African-America
Marital Status
Married
Single

Education
Completed high school or
more
Did not complete high
school
Occupation
Professional
Non professional
Co-morbidity
Yes
No
Ostomy
Yes
No
Adjuvant Therapy
Yes
No
Interfering substances and
states
Yes
No
Stage
Early
Late
N=63
(Orsi, McCorkle et al., 1996)

26 (57%)
20 (43%)

10 (59%)
7 (41%)

23 (50%)
23 (50%)

4 (24%)
13 (4%)

18 (39%)
28 (61%)

7 (41%)
10(59%)

19 (41%)
27 (59%)

2 (12%)
15 (88%)

23 (50%)
23 (50%)

7 (41%)
10 (59%)

9 (20%)
37 (35%)

4 (24%)
13 (76%)

30 (65%)
16 (35%)

9 (24%)
8 (76%)

In the sample available to this researcher, a descriptive analysis was performed
for both depression scores and NK cell levels. Women exhibited higher depression
scores as measured by the BDI at all points in time (pre-op, one week post-op, 1 month
post-op, and three months post-op), but the results were not statistically significant
F(3,159) = 1.21, p = .303 (partial n = .022), and Greenhouse-Geisser = .68. The small
effect size and small sample size (21) require that results be interpreted with caution.
Individual histograms of the depression scores at each sampling point revealed that the
scores were not normally distributed. All were positively skewed, making statistical
inferences more difficult. To this end, the Greenhouse-Geisser correction was employed
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to make the analysis more robust. A logarithmic transformation was considered, but did
not increase the analytic power, and so was discarded.
General estimating equation analysis was used to test for differences between the
mean scores for depression and NK cell levels at three points in time across the illness
trajectory, and between the two genders (Hanley, Negassa et al., 2003). General
estimating equations (GEE) are of particular value when the data to be analyzed consist
of longitudinal data, correlated data, in studies with considerable missing data points, or
if the data are binary or counts (Hanley, Negassa et al., 2003). The GEE analysis is a
regression analysis based on the General Linear Model (GLM), and develops a regression
equation for each set of data points to impute missing data. The GEE method assumes
that the model being tested is linear, and that any missing data are missing completely at
random (Horton & Lipsitz, 1999; Norton, Bieler et al., 1996). General Estimating
Equations are a synthesis of Feasible Generalized Least Squares approach and are of
particular value in data sets with missing data. General Estimating Equations produce
reasonably accurate standard errors, which produces confidence intervals with the correct
coverage rates (Hanley, Negassa et al., 2003).
Table 6
Mean BDI Scores by Gender
PreOp

1 Week

1 Month

3 Months

Male

6.0

7.9

6.5

5.3

Female

7.6

9.2

9.6

6.3

The analysis for time reveals that the largest depression scores on the BDI were reported
at one week after surgery, and that depression scores progressively declined from that
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peak to a low at three months for men. In women, the highest depression scores on the
BDI were reported at one month after surgery, and the lowest at the three month mark.
Both men and women reported lower depression scores at three months than
preoperatively. No data were available on the mobilization of social and family supports
for the participants after the diagnosis, but presumably this did occur. More than three
quarters of the sample (77%) were married, and it is reasonable to assume that there was
spousal support.
Table 7
Mean NK levels by Gender
PreOp

1 Week

3 Months

Male

257

261

267

Female

254

251

238

Women in the sample available to this researcher exhibited lower NK cell levels
preoperatively, at one week, and lower scores at 3 months than men. Individual
histograms of the NK cell levels at each sampling point revealed that the levels were not
normally distributed. All were positively skewed, making statistical inferences more
difficult. The Greenhouse-Geisser correction was employed to make the analysis more
robust. Logarithmic transformation did not increase the power of the analysis, and was
not used.
Data Analysis Related to the Research Question
Research Question 1

Are women more likely to report more depressive symptoms than

men in adult patients diagnosed with colorectal cancer at four points in time (pre-surgical,
1 week post-surgery, one month post-surgery, and three months post surgery)?
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While women did report higher depression scores than men at all points in time,
the results were not statistically significant (B=2.065,p=A5l). Age was also statistically
significant (B=4.180,/?=041).
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Table 8 Beck Depression Scores and Gender:
2 (Group) by 4 (Time) General Estimating Equation and Multi-Level Modeling (A^= 117)

Variables (Range)

Men

Women

F

X (SD)

X (SD)

Group

Beck Depression Score (0-63)
Timel(n=71)

5.96(6.39)

Time 2 (n=60)

7.93 (8.53)

Time3(n=59)

6.54 (7.19)

Time4(n=58)

5.34 (6.49)

P

2.065
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4.18

.041

Beck Depression Score (0-63)
Time 1 (n==46)

7.56 (5.86)

Time2(n=32)

9.19(6.48)

Time3(n=28)

9.61(5.86)

Time 4 (n=32)

6.28 (6.20)

Age (Men, 25-82)

Age (Women,30-87)

62.6(12.8)

62(12.8)

W

.022
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c

Partial eta squared values are for the interactions only. Effect sizes: Small = .01, Medium = .06, Large = .1
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Research Question 2

Do women demonstrate lower NK cell levels in adult patients

diagnosed with colorectal cancer at three points in time (pre-surgical, one week postsurgery, and three months post surgery)?
Women did not demonstrate statistically significantly lower NK cell levels than
men (B=.271, p-.603) using GEE, although at all points in time, men's NK cell levels
were higher than women's. Age was not a significant factor in NK cell level differences
(B=3.667,;?=056).
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Table 9 Natural Killer Cell Levels and Gender:
2 (Group) by 3 (Time) General Estimating Equations (A^= 117)

Variables (Range)

Men

Women

F

X (SD)

X (SD)

Group

Natural Killer Cell Levels (42811)

P

.239

.625

2.977

.084

257(156)

Time 1 (n=55)

261 (178)

Time2(n=41)

267(173)

Time 4 (n=35)

Natural Killer Cell Levels (42254(155)

811)
Time 1 (n=34)

251 (138)

Time 2 (n=21)

238(120)

Time 4 (n=20)

Age (Men, 25-82)
Age (Women, 30-78)

62.6(12.8)
62 (12.8)

V
.014

47
'Partial eta squared values are for the interactions only. Effect sizes: Small = .01, Medium = .06, Large = .15
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Summary
This chapter presented the data analysis results for the research questions in three
sections. The first section described the sample. Section two discussed the analysis of
the effect of sex on depression scores. Section three described the influence of sex on
natural killer cell levels. An assessment of effect size was included in sections two and
three. There was no statistically significant association between sex and depression
scores, and no statistically significant association between sex and NK cell levels. Age
was a statistically significant factor in depression scores using the GEE analysis and the
multi-level model, but was not significant in either analysis for effects on NK cell levels.

CHAPTER V
SUMMARY, DISCUSSION, IMPLICATIONS, AND CONCLUSION
This chapter includes a summary of the research design and method, discussion of
the research findings, implications for nursing practice, education, and research, and the
conclusion of the research study.
Summary of the Research Design and Method
The purpose of this was to examine the relationship between gender, depression,
and immune system status in individuals undergoing treatment for colorectal cancer at the
University of Pennsylvania between 1990 and 1991. The conceptual framework for the
study was based on McCorkle's work integrating expectations about outcome of cancer
treatment, depression, and immune response in person recovering from surgery for
colorectal cancer, and research asserting that women experience more depression than
men when diagnosed with cancer. Depression was defined as the participant's score on
the Beck Depression Inventory, and immune system status was defined as the
participant's natural killer cell level. Depression was assessed at four points in time:
preoperatively, one week, one month, and three months post-surgery. Immune system
status was assessed at three points in time: preoperatively, one week, and one month
post-surgery.
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The following research questions were addressed:
1. Are women more likely to report more depressive symptoms than men in adult
patients diagnosed with colorectal cancer at four points in time (pre-surgical, 1 week
post-surgery, one month post-surgery, and three months post surgery)?
2. Do women demonstrate lower NK cell levels in adult patients diagnosed with
colorectal cancer at three points in time (pre-surgical, one week post-surgery, and three
months post surgery)?
Data provided by the original researcher, collected between 1990 and 1991, were
analyzed using SPSS for Windows. Descriptive statistics were reported by the original
researcher, and inferential statistics were used by this researcher to examine the
relationships between the study variables of gender, depression, and immune system
status. The results of the study did not support a link between gender and depression, or
between gender and immune system status. However, the lack of power was a
confounding factor. A discussion of the results of the study is presented in the next
section of this chapter.
Discussion
Descriptive Characteristics of the Sample and Study Variables
Results for the two research questions on the effects of gender on Depression and
the Immune System will be discussed separately due to differing numbers in each sample.
Research Question 1: Are women more likely to report more depressive symptoms than
men in adult patients diagnosed with colorectal cancer at four points in time (pre-surgical,
1 week post-surgery, one month post-surgery, and three months post surgery)?
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A total of 117 people with colorectal cancer participated in the study, but the drop
out rate was high, and contributed to the lack of power. Of the 117, 55 completed the
depression score inventories at three points: prior to surgery, one week post-surgery, one
month post-surgery, and three months post-surgery. The sample consisted of 34 men
(62%) and 21 women (38%). The sample was overwhelmingly Caucasian (90%) and
married (77%). The majority of participants (57%) had completed college, and most
worked or had worked as either skilled workers (50%) or as professionals (45%). Their
ages ranged from 28 years to 88 years, with a mean of 63 years. According to the
American Cancer Society(ACS, 2005), the incidence of colorectal cancer is more than 50
times higher in patients aged 60 years to 79 years than in those younger than in those
aged less than 40 years old. In these respects, the study participants differ from the
American Cancer Society's description of people with colorectal cancer. The sample
included only 10% African-Americans, and the number of patients aged 60 years to 79
years with colorectal cancer was seven times greater than those aged less than 40 years.
According to data released in 2005, 91% of new cases occur in patients older than 50
years, and the incidence is 35% higher in men than in women (ACS, 2005). Colorectal
cancer incidence is approximately 15% higher in African-American men and women than
in Caucasian men and women in the general population than in this sample. AfricanAmerican patients are more likely to be diagnosed with colorectal cancer that has already
metastasized than Caucasians, and are less likely to receive chemotherapy and adjuvant
therapies than Caucasians (ACS, 2005). No data on chemotherapy and adjuvant therapies
stratified by race were available, and the small number of African-American participants
makes any conclusions risky. The sample consisted of 61% men and 39% women with
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colorectal cancer. The men represent a 56% increase in the incidence of colorectal
cancer, in contrast to the ACS statistics, which state that the incidence and mortality of
colorectal cancer is more than 35% higher in men than women (ACS, 2005).
Women reported more depressive symptoms than men at every point in time, but
the results were not statistically significant using both General Estimating Equations and
Multi-level Modeling analyses. The small effect size and small sample size make the
results difficult to trust. The lack of power made conclusions about the effect of gender
difficult.
Analysis did reveal a significant main effect for age on depression scores. This
result has been previously reported (Orsi, McCorkle et al., 1996). The analysis for time
reveals that the largest depression scores on the BDI were reported at one week after
surgery, and that depression scores progressively declined from that peak to low at three
months. Both men and women reported lower depression scores at three months than
preoperatively. Some of this change in depression scores can be attributed to the effects
of being involved in an altruistic endeavor, the study itself. No data were available on the
mobilization of social and family supports for the participants after the diagnosis, but
presumably this did occur. More than three quarters of the sample (77%) were married,
and it is reasonable to assume that there'was spousal support.
There were not significant changes in the number of participants in the
Depression Score portion of the study. In all probability, this is due to the nature of the
instrument used, the Beck Depression Inventory. The BDI can be self-administered or
the data can be collected in an interview. Neither method is particularly intrusive, and

53

there is no physical pain associated with the test, as is the case for the phlebotomy
required to obtain NK cell results.
Research Question 2:

Do women demonstrate lower NK cell levels in adult patients

diagnosed with colorectal cancer at three points in time (pre-surgical, one week postsurgery, and three months post surgery)?
Women did demonstrate lower NK cell levels than men at all sample times (preoperative, one week, and three months, but the results were not statistically significant.
There was no significant effect for time, ignoring sex. The results were complicated again
by the small sample size and the decreasing number of participants over time. The
number of participants declined from 60 at the pre-operative sample to 51 at one week,
and 45 at three months. Only 16 women were participating by the three month time
frame.
The high attrition rate for women was especially troubling, since colorectal cancer
strikes almost as many women as breast cancer. Yet data on women are lacking. No data
were available from the original researchers regarding the reasons for the women
dropping out of the study.
Implications for Nursing
Nursing Education

This study has implications for nursing education, in that little attention continues
to be paid to the impact of disease states on women. The majority of the patients in this
study were men, and a significant effect was found between time and depression.
According to the World Health Organization (WHO), depression represents one of the
most burdensome diseases facing the world (WHO, 2002). Depression occurs in up to 20
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percent of patients with chronic medical illnesses such as diabetes and heart disease, and
presumably, colorectal cancer. Depression is also associated with an approximately 50%
increase in medical costs of chronic medical illness (Katon 2003).

Women are at greater risk for late-life depression, coinciding with the most likely
years for a diagnosis of colorectal cancer. The prevalence of depression is higher in
women across all age groups. Several factors may account for the disproportionate
prevalence of depression in older women: greater susceptibility to depression, greater
persistence of depression after its onset, and lower mortality (Barry, Allore et al., 2008).
Although the gender gap in depression prevalence narrows with increasing age, women
remain at higher risk (Kornstein, 1997). Women make up the majority of nurses and
nursing students, yet nursing education focuses little to no attention on the psychological
and physiological differences between men and women. The women in this admittedly
small sample consistently reported more depressive symptoms, and demonstrated lower
NK cell levels. While the results were not statistically significant, the potential
implications should be considered in teaching. According to literature, women are much
more likely to report depression than men, yet women are treated less often and less
effectively. Nursing education needs to emphasize the special needs of women in
recovering from major surgery such as colorectal surgery, and in the course of coping
with a life-threatening disease. Social support may also influence depression and coping
differently in women than in men. In 2005, Kristofferzon, Lofmark, and Carlsson, studied
74 women and 97 men diagnosed with myocardial infarction in Sweden. The women
used more evasive and supportive coping, and rated psychological aspects of the heart
disease as more problematic to manage. More women perceived available support from
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friends and grandchildren, and more men perceived available support from their partner (
Kristofferzon, Lofmark,& Carlsson, 2005). Manning-Walsh (2005) studied 100 women
with breast cancer, and found that social support from friends and family members helped
decrease the negative effects of symptoms on quality of life (Manning-Walsh, 2005).
Considerable differences exist, moreover, between sources of social support in men and
women. Gass, Weitzen, Clark, and Dizon studied 135 women diagnosed with breast
cancer, 75% of whom were married or partnered. Asked to name their primary support,
emergency contact, and health care proxy, more than 40% of women did not name the
same person to these distinct roles. Even for women in relationships, almost 50% did not
name their partner to all 3 support roles. (Gass, Weitzen, Clark, et. al., 2007). It would be
particularly interesting to study the effects of non-spousal support on coping with cancer
in married men and married women. In addition, comparing the sources of support in
married and single women with cancer could provide insight into designing support
systems for those women facing a diagnosis of cancer.

Nursing Research
This study presents a number of issues for nursing research. Women represent
46% of all patients diagnosed with colorectal cancer, yet this is the only longitudinal
study to address the effects of the disease on their state of mind and their immune
systems. A great deal of attention was paid to the Couric effect on colorectal cancer
screening rates, but little attention has focused on the effects of the treatment course on
women. Women have long been known to have an increased risk of depression, but there
have been no intervention studies published which focus on how to treat depression in
women with colorectal cancer.
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The small number of women participating in this study makes additional research
imperative. The sample also did not include significant numbers of African-American
participants, yet this group has a 15% higher incidence of colorectal cancer, and a 40%
higher mortality (ACS, 2005). Additional research on the impact of the disease and its
treatment on depression and immune system status in the African-American population
must be undertaken.
This study used NK cell levels as a marker of immune system function. It would
be helpful to investigate immune system function, such as infection to determine if the
NK cell levels are clinically significant.
Summary of recommendations for further study
Additional research is needed in women with colorectal cancer, and in AfricanAmericans with colorectal cancer. Studies to determine the efficacy of interventions to
combat depression in women and improve immune system status would be particularly
helpful. Additional work is needed to determine if the depression levels and immune
system changes are clinically significant.
Conclusion
This secondary analysis examined the influence of sex on depression and immune
status in patients with colorectal cancer over a three month period. No significant effects
were found, but the study was confounded by the small sample size. A significant main
effect for time was found on depression in the entire sample, but not in separate sexes.
Additional research is needed to examine the impact of sex on depression and immune
status, and to look for clinically significant changes, if any, in this patient population.
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Appendix A
TNM Definitions
Primary Tumor (T)
Definitions

TX: Primary tumor cannot be
assessed
TO: No evidence of primary
tumor
Tis: Carcinoma in situ:
intraepithelial or invasion of
the lamina propria.
Tl: Tumor invades submucosa
T2: Tumor invades muscularis
propria
T3: Tumor invades through
the muscularis propria into the
subserosa or into
nonperitonealized pericolic or
perirectal tissues
T4: Tumor directly invades
other organs or structures
and/or perforates visceral
peritoneum

Regional Lymph
Nodes
NX: Regional
nodes cannot be
assessed

Distant Metastasis

NO: No regional
lymph node
metastasis

MO: No distant
metastasis

Nl: Metastasis in 1
to 3 regional
lymph nodes
N2: Metastasis in 4
or more regional
lymph nodes

MX: Distant
metastasis cannot
be assessed

Ml: Distant
metastasis
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Colon Cancer and Rectal Cancer TNM Stages
Treatment

Stage

Tumor/Node/Metastasis

0
Cancer in
situ
I
Cancer in
the
mucosa
II A

Tis,N0,M0

Local excision or
polypectomy

T1,N0,M0
T2, NO, MO

Open surgical
resection and
anastamosis

T3, NO, MO

II B

T4, NO, MO

III A

T1,N1,M0
T2,N1,M0

III B

T3,N1,M0
T4,N1,M0

III C

Any T, N2, MO

Open surgical
resection with or
without
anastamosis,
chemotherapy,
radiation therapy,
biologic therapy
Open surgical
resection with or
without
anastamosis,
chemotherapy,
radiation therapy,
biologic therapy
Open surgical
resection with or
without
anastamosis,
chemotherapy,
radiation therapy,
biologic therapy
Open surgical
resection with or
without
anastamosis,
chemotherapy,
radiation therapy,
biologic therapy
Open surgical
resection with or
without
anastamosis,
chemotherapy,

Prognosis
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Any T, Any N, Ml

IV

radiation therapy,
biologic therapy
Open surgical
resection with or
without
anastamosis,
chemotherapy,
radiation therapy,
biologic therapy

In the past, colorectal cancer was staged primarily according to the Duke's classification
system. The Duke's system sorted tumors into four categories (A, B, C, D) according to
the extent of tumor penetration into the colon, surrounding tissue, and distant sites.
Dukes Stages of Colon Cancer
Stage

A '

B

TNM
Classification

I

II

C

III

D

IV

Extent of Tumor
Cancer has spread beyond the
innermost lining of the colon
and/or rectum to the second and
third layers and involves the
inside wall of the colon and/or
rectum, but it has not spread to
the outer wall or outside the
colon and/or rectum.
Cancer has spread outside the
colon and/or rectum to nearby
tissue, but it has not gone into
the lymph nodes

Tumor cells have spread to
organs and lymph nodes near
the colon/rectum

Cancer may have spread to
nearby lymph nodes and has

Prognosis
97% 5 year survival

80% 5 year survival; if
locally-invasive,
dramatically worse
prognosis
CI: only a few nodes are
involved near the primary
growth and the proximal
nodes are free from
metastases, 65% 5 year
survival.
C2: proximal nodes are
involved, 35% 5 year
survival
less than 5% 5 year
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spread to other parts of the
body, such as the liver or lungs.

survival

